Skip to content
Catalyst

(4S)-4-hydroxy-L-isoleucineFinding

(4S)-4-hydroxy-L-isoleucine decreases total cholesterol (TC)

lowersInsufficient evidenceFinding

01 · The sentence it was drawn from

“4-Hydroxyisoleucine, when given orally to these mice at 50 mg kg(-1) dose level, significantly (p < 0.05) declined their elevated blood glucose, plasma insulin, triglycerides, total cholesterol, low-density lipoprotein-cholesterol levels and raised their declined plasma high-density lipoprotein-cholesterol level.”
Quoted verbatim from Antihyperglycaemic effect of an unusual amino acid (4-hydroxyisoleucine) in C57BL/KsJ-db/db mice.
This finding among the 130 findings on its endpoint

(4S)-4-hydroxy-L-isoleucine

Total cholesterol (TC)

lowers

Who
C57BL/KsJ-db/db mice, a model of type II diabetes
Dose studied
4-hydroxyisoleucine 50 mg/kg orally

Insufficient evidencePMID 20140804 · 2010

02 · The study

Study
animal · not in humans
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limited
  • insufficientthis finding

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7EX6NN2TCNRE4ABPBSFNSM9